Reduce, reuse, and recycle

Reducing a cytokine's affinity for its receptor increases its ability to be reused and recycled, and could enhance its therapeutic potency.

[1]  D A Lauffenburger,et al.  Intracellular Trafficking of Epidermal Growth Factor Family Ligands Is Directly Influenced by the pH Sensitivity of the Receptor/Ligand Interaction (*) , 1995, The Journal of Biological Chemistry.

[2]  R. Derynck,et al.  Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. , 1991, Cell regulation.

[3]  D. Lauffenburger,et al.  Receptor‐mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor α , 1996, Journal of cellular physiology.

[4]  D. Lauffenburger,et al.  Receptors: Models for Binding, Trafficking, and Signaling , 1993 .

[5]  D. Lauffenburger,et al.  Rational cytokine design for increased lifetime and enhanced potency using pH-activated “histidine switching” , 2002, Nature Biotechnology.

[6]  F. Martin-Christin.  Granulocyte colony stimulating factors: How different are they? How to make a decision? , 2001, Anti-cancer drugs.

[7]  N. Kunishima,et al.  Atomic structure of the GCSF–receptor complex showing a new cytokine–receptor recognition scheme , 1999, Nature.

[8]  Theodore W Randolph,et al.  Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition. , 2002, Biochemistry.

[9]  W. Liles,et al.  Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. , 2002, The Journal of infectious diseases.